Astellas Pharma to acquire OSI Pharmaceuticals - MarketLine Financial Deals

Astellas Pharma to acquire OSI Pharmaceuticals

Astellas Pharma to acquire OSI Pharmaceuticals - MarketLine Financial Deals
Astellas Pharma to acquire OSI Pharmaceuticals
Published Mar 01, 2010
4 pages — Published Mar 01, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Astellas Pharma, Inc., a Japan-based pharmaceutical company, intends to commence a cash tender offer to acquire all the outstanding shares of OSI Pharmaceuticals, Inc.

  
Source:
Document ID
MA20774_100309
Country
Country
Ticker
4503=JP
Ticker
OSIP=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Astellas Pharma to acquire OSI Pharmaceuticals" Mar 01, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Astellas-Pharma-to-acquire-OSI-Pharmaceuticals-2052-26853>
  
APA:
MarketLine Financial Deals. (2010). Astellas Pharma to acquire OSI Pharmaceuticals Mar 01, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Astellas-Pharma-to-acquire-OSI-Pharmaceuticals-2052-26853>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.